Semma Therapeutics

About:

Semma Therapeutics was founded to develop transformative therapies for Type 1 diabetes patients.

Website: http://www.semma-tx.com/

Twitter/X: semmatx

Top Investors: F-Prime Capital, ARCH Venture Partners, Novartis, Medtronic, Eight Roads Ventures

Description:

Semma Therapeutics was founded to develop transformative therapies for Type 1 diabetes patients. Recent work in the laboratory of Professor Douglas Melton led to the discovery of a method to generate billions of functional, insulin-producing beta cells in the laboratory. This breakthrough technology has been exclusively licensed to Semma Therapeutics for the development of a cell-based therapy for diabetes. Ongoing research at Semma Therapeutics is focused on combining these proprietary cells with a state-of-the-art device to provide a true replacement for the missing beta cells in a diabetic patient without immunosuppression. Semma Therapeutics is working to bring this new therapeutic option to the clinic and improve the lives of patients with diabetes.